Choosing a metric for measurement of pre-exposure prophylaxis

Claire C Bristow¹, Kelika A Konda², Jordan Wong³, Carlos F Caceres⁴, Jeffrey D Klausner⁵

Affiliations

¹ Fielding School of Public Health, University of California Los Angeles, 9911 W Pico Blvd, St 955, CA 90035, USA. Electronic address: ccbristow@gmail.com.
² David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
³ Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁴ School of Public Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
⁵ Fielding School of Public Health, University of California Los Angeles, 9911 W Pico Blvd, St 955, CA 90035, USA; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

PMID: 25455980
PMCID: PMC4507263
DOI: 10.1016/S1473-3099(14)70989-2

Comment

Choosing a metric for measurement of pre-exposure prophylaxis

Claire C Bristow et al. Lancet Infect Dis. 2014 Dec.

. 2014 Dec;14(12):1177-8.

doi: 10.1016/S1473-3099(14)70989-2. Epub 2014 Nov 17.

Authors

Claire C Bristow¹, Kelika A Konda², Jordan Wong³, Carlos F Caceres⁴, Jeffrey D Klausner⁵

Affiliations

¹ Fielding School of Public Health, University of California Los Angeles, 9911 W Pico Blvd, St 955, CA 90035, USA. Electronic address: ccbristow@gmail.com.
² David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
³ Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁴ School of Public Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
⁵ Fielding School of Public Health, University of California Los Angeles, 9911 W Pico Blvd, St 955, CA 90035, USA; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

PMID: 25455980
PMCID: PMC4507263
DOI: 10.1016/S1473-3099(14)70989-2

No abstract available

PubMed Disclaimer

Comment on

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, Goicochea P, Grant RM. Buchbinder SP, et al. Lancet Infect Dis. 2014 Jun;14(6):468-75. doi: 10.1016/S1473-3099(14)70025-8. Epub 2014 Mar 7. Lancet Infect Dis. 2014. PMID: 24613084 Free PMC article. Clinical Trial.

References

1. Buchbinder SP, Glidden DV, Liu AY, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis. 2014;14:468–475. - PMC - PubMed
1. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2008. Population-attributable fractions and impact fractions; p. 67.
1. Guy RJ, Wand H, Wilson DP, et al. Using population attributable risk to choose HIV prevention strategies in men who have sex with men. BMC Public Health. 2011;11:247. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

R01 AI099727/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Choosing a metric for measurement of pre-exposure prophylaxis

Affiliations

Choosing a metric for measurement of pre-exposure prophylaxis

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical